» Articles » PMID: 38792620

Characterization Methods for Nanoparticle-Skin Interactions: An Overview

Abstract

Research progresses have led to the development of different kinds of nanoplatforms to deliver drugs through different biological membranes. Particularly, nanocarriers represent a precious means to treat skin pathologies, due to their capability to solubilize lipophilic and hydrophilic drugs, to control their release, and to promote their permeation through the stratum corneum barrier. A crucial point in the development of nano-delivery systems relies on their characterization, as well as in the assessment of their interaction with tissues, in order to predict their fate under in vivo administration. The size of nanoparticles, their shape, and the type of matrix can influence their biodistribution inside the skin strata and their cellular uptake. In this respect, an overview of some characterization methods employed to investigate nanoparticles intended for topical administration is presented here, namely dynamic light scattering, zeta potential, scanning and transmission electron microscopy, X-ray diffraction, atomic force microscopy, Fourier transform infrared and Raman spectroscopy. In addition, the main fluorescence methods employed to detect the in vitro nanoparticles interaction with skin cell lines, such as fluorescence-activated cell sorting or confocal imaging, are described, considering different examples of applications. Finally, recent studies on the techniques employed to determine the nanoparticle presence in the skin by ex vivo and in vivo models are reported.

Citing Articles

A Novel Natural Penetration Enhancer for Transdermal Drug Delivery: In Vitro/In Vivo Evaluation and Penetration Enhancement Mechanism.

Zhao N, Hao J, Zhao Y, Zhao B, Lin J, Song J Pharmaceutics. 2025; 17(2).

PMID: 40006621 PMC: 11859311. DOI: 10.3390/pharmaceutics17020254.


Multicore, SDS-Based Polyelectrolyte Nanocapsules as Novel Nanocarriers for Paclitaxel to Reduce Cardiotoxicity by Protecting the Mitochondria.

Szwed M, Poczta-Krawczyk A, Kania K, Wiktorowski K, Podsiadlo K, Marczak A Int J Mol Sci. 2025; 26(3).

PMID: 39940670 PMC: 11817011. DOI: 10.3390/ijms26030901.

References
1.
Lee P, Chen B, Gollavelli G, Shen S, Yin Y, Lei S . Development and validation of TOF-SIMS and CLSM imaging method for cytotoxicity study of ZnO nanoparticles in HaCaT cells. J Hazard Mater. 2014; 277:3-12. DOI: 10.1016/j.jhazmat.2014.03.046. View

2.
Khan S, Sharma A, Jain V . An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes. Adv Pharm Bull. 2023; 13(3):446-460. PMC: 10460807. DOI: 10.34172/apb.2023.056. View

3.
Cappellozza E, Boschi F, Sguizzato M, Esposito E, Cortesi R, Malatesta M . A spectrofluorometric analysis to evaluate transcutaneous biodistribution of fluorescent nanoparticulate gel formulations. Eur J Histochem. 2022; 66(1). PMC: 8859714. DOI: 10.4081/ejh.2022.3321. View

4.
Tofani R, Sumirtapura Y, Darijanto S . Formulation, Characterisation, and in Vitro Skin Diffusion of Nanostructured Lipid Carriers for Deoxyarbutin Compared to a Nanoemulsion and Conventional Cream. Sci Pharm. 2017; 84(4):634-645. PMC: 5198023. DOI: 10.3390/scipharm84040634. View

5.
Ferreira M, Ogren M, Dias J, Silva M, Gil S, Tavares L . Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance. Molecules. 2021; 26(7). PMC: 8038399. DOI: 10.3390/molecules26072047. View